Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival
Published Online: 2010-01-?
Journal: The Lancet Oncology•Publisher: Elsevier BV
Authors: Christopher U Jones•David Raben•Eric K Rowinsky•Hagop Youssoufian•James A Bonner•Jordi Giralt•Jose Baselga•Junming Zhu•K Kian Ang•Paul M Harari•Ranjan K Sur•Roger B Cohen•Sharon A Spencer
